Literature DB >> 11724448

Cardiovascular autonomic dysregulation and fatigue in multiple sclerosis.

S Merkelbach1, U Dillmann, C Kölmel, I Holz, M Muller.   

Abstract

Both cardiovascular disturbances and fatigue are frequent in multiple sclerosis (MS). We investigated their relationship in 84 MS patients (mean age 39.9 +/- 8.9 years) using five established autonomic tests and three different fatigue questionnaires. 64.2% of the patients were categorised as being fatigued Fatigue perception was weakly related to EDSS. Moderate cardiovascular disturbances were found in 16.6% of the patients, and 10.7% had severe cardiovascular autonomic abnormalities. Cardiovascular dysfunction was slightly related to age and to EDSS. In 19.4% of all patients signs of autonomic failure and fatigue were co-existent Using correlation analysis, we found only weakly significant correlation coefficients between some single autonomic test parameters and fatigue scores, which were confounded by age effects. The analysis of dichotomised data revealed slightly significant differences in fatigue experience between patients with and without abnormalities regarding the handgrip test and the Valsalva reaction. Thus, autonomic disturbances might contribute to fatigue symptoms in a MS subgroup, but the overall influence of the autonomic cardiovascular regulation towards fatigue experience seems to be of minor relevance.

Entities:  

Mesh:

Year:  2001        PMID: 11724448     DOI: 10.1177/135245850100700508

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  18 in total

Review 1.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

2.  Difficulties in the diagnosis of autonomic dysfunction in multiple sclerosis.

Authors:  Beata Labuz-Roszak; Krystyna Pierzchala
Journal:  Clin Auton Res       Date:  2007-10-19       Impact factor: 4.435

3.  Ventromedial prefrontal cortex modulates fatigue after penetrating traumatic brain injury.

Authors:  Matteo Pardini; Frank Krueger; Vanessa Raymont; Jordan Grafman
Journal:  Neurology       Date:  2010-03-02       Impact factor: 9.910

4.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 5.  Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis.

Authors:  D S Kasatkin; N N Spirin
Journal:  Neurosci Behav Physiol       Date:  2007-03

6.  Autonomic disorders in multiple sclerosis.

Authors:  E Lensch; W H Jost
Journal:  Autoimmune Dis       Date:  2011-04-17

7.  Unveiling the relationship between autonomic involvement, fatigue, and cognitive dysfunction in early relapsing-remitting multiple sclerosis.

Authors:  Alessandro Dinoto; Sara Baldini; Maria Elisa Morelli; Fulvio Pasquin; Alessio Bratina; Antonio Bosco; Arianna Sartori; Paolo Manganotti
Journal:  Neurol Sci       Date:  2021-08-02       Impact factor: 3.307

Review 8.  Autonomic dysfunction in multiple sclerosis.

Authors:  Carl-Albrecht Haensch; Johannes Jörg
Journal:  J Neurol       Date:  2006-02       Impact factor: 4.849

9.  Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism.

Authors:  Gaia Tabacco; Anda Mihaela Naciu; Roberto Cesareo; Daria Maggi; Claudio Pedone; Diana Lelli; Assunta Santonati; Daniela Bosco; Alfonso Maria Di Tommaso; Paolo Pozzilli; Silvia Manfrini; Andrea Palermo
Journal:  Endocrine       Date:  2019-10-03       Impact factor: 3.633

10.  Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek
Journal:  Clin Auton Res       Date:  2018-09-12       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.